Split luciferase-based assay to detect botulinum neurotoxins using hiPSC-derived motor neurons

9Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Botulinum neurotoxins (BoNTs) have been widely used clinically as a muscle relaxant. These toxins target motor neurons and cleave proteins essential for neurotransmitter release like Synaptosomal-associated protein of 25 kDa (SNAP-25). In vitro assays for BoNT testing using rodent cells or immortalized cell lines showed limitations in accuracy and physiological relevance. Here, we report a cell-based assay for detecting SNAP-25-cleaving BoNTs by combining human induced Pluripotent Stem Cells (hiPSC)-derived motor neurons and a luminescent detection system based on split NanoLuc luciferase. This assay is convenient, rapid, free-of-specialized antibodies, with a detection sensitivity of femtomolar concentrations of toxin, and can be used to study the different steps of BoNT intoxication.

Cite

CITATION STYLE

APA

Cotter, L., Yu, F., Roqueviere, S., Duchesne de Lamotte, J., Krupp, J., Dong, M., & Nicoleau, C. (2023). Split luciferase-based assay to detect botulinum neurotoxins using hiPSC-derived motor neurons. Communications Biology, 6(1). https://doi.org/10.1038/s42003-023-04495-w

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free